Nanomaterials for Photodynamic Therapy

Häftad, Engelska, 2023

Av Prashant Kesharwani, India) Kesharwani, Prashant, PhD (Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar, Madhya Pradesh

3 219 kr

Beställningsvara. Skickas inom 7-10 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

Nanomaterials for Photodynamic Therapy takes a unique approach to this area, with a key focus on the use of nanomaterials and nanocarriers for photodynamic therapy (PDT). The book introduces the history and mechanism of action behind PDT, covering the variety of sensitizers currently available. Subsequent chapters review existing and emerging nanomaterials for PDT, including hydrogel nanocomposites, fullerenes, quantum dots, polymeric micelles, and more. Challenges and translational aspects of PDT are also discussed, touching on the issues and hindrances of drug resistant cancers.

The book bridges the gap between the physics and clinical aspects of PDT, offering a unique nanomaterials-focused perspective. This book will prove useful for materials scientists, biomedical engineers, electrical and optical engineers, and pharmaceutical scientists interested in cancer treatment.

Reviews a broad range of nanomaterials for PDT, such as graphene oxide, dendrimers, solid lipid nanoparticles, and more
Provides a helpful introduction to the history and mechanism of action behind PDT
Discusses challenges in clinical translational, particularly in drug-resistant cancers

Produktinformation

Utgivningsdatum2023-01-17
Mått152 x 229 x 30 mm
Vikt1 000 g
FormatHäftad
SpråkEngelska
SerieWoodhead Publishing Series in Biomaterials
Antal sidor568
FörlagElsevier Science
ISBN9780323855952

Tillhör följande kategorier

Dr. Prashant Kesharwani is assistant professor of Pharmaceutics at Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar, Madhya Pradesh, India. He has more than 12 years of teaching, research, and industrial experience at international levels from various countries, including the United States, Malaysia, and India. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has more than 350 international publications in well-reputed journals and more than 25 international books (Elsevier). He is a recipient of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards, such as “USERN Laureate award, most prestigious “SERB-Ramanujan Fellowship Award. He actively participates in outreach and scientific dissemination for the service of the wider community. His Number of citations is = 26779; h-index = 85; i-10 index = 370 (According to google scholar on March 2025). He has more than 30 international publications published in very high impact factor journals (Progress in Polymer Sciences IF 32.063, Molecular Sciences IF 41.444, Progress in Material Sciences IF 48.580, Advanced Materials IF 29.4, Drug Resistance Update IF 22.841 and Material Todays IF 32.072). He has presented many invited talks and oral presentations at prestigious scientific peer-conferences, received international acclaims and awards for research contribution, supervised students/junior researchers and actively participated in outreach and scientific dissemination for the service of the wider community.

1. A Narrative History of Photodynamic Therapy2. Mechanisms of photodynamic therapy3. Mechanisms of photodynamic therapy in cancer treatment4. Sensitizers in photodynamic therapy5. Polymeric micelles mediated photodynamic therapy6. Liposomes in photodynamic therapy7. Organic nanoparticles in photodynamic therapy8. Lipid nanoparticles in photodynamic therapy9. Solid lipid nanoparticles in photodynamic therapy10. Actively targeted nanoparticles in photodynamic therapy11. Dendrimers in photodynamic therapy12. Carbon materials for photodynamic therapy13. Fullerenes in photodynamic therapy14. Quantum Dots in photodynamic therapy15. Photodynamic therapy in cosmetics16. Translational aspects of photodynamic therapy in drug resistant cancers17. Towards photodynamic chemotherapy with C60-drug-nanocomplexes18. Challenges, conclusion and future perspective of photodynamic therapy